Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely since the study focuses on web-based resilience tools and surveys.
The available research does not provide specific data on the effectiveness of WISER for Burnout. Instead, it focuses on the implementation of patient-reported outcomes in various healthcare settings, such as oncology and psychiatric care. These studies highlight the importance of integrating patient feedback into treatment plans, which can improve patient engagement and care delivery. However, there is no direct evidence from the provided information that supports the effectiveness of WISER for Burnout specifically.
12345The randomized controlled trial titled 'Randomized controlled trial of the "WISER" intervention to reduce healthcare worker burnout' specifically evaluates the WISER intervention. However, the provided abstracts do not contain detailed safety data or outcomes related to the WISER intervention. Further investigation into the full text of this study or additional studies on WISER would be necessary to obtain comprehensive safety data.
678910Eligibility Criteria
The WISER Study is for adults over 18, including healthcare workers from Duke University Health System and other health systems. It's aimed at those interested in using web-based tools to build resilience against stress, depression, and burnout.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in well-being tools immediately for 1 week
Waitlist Control
Participants wait 1 week before beginning the well-being tools
Follow-up
Participants are monitored for changes in emotional exhaustion, recovery, and work-life integration
Participant Groups
WISER is already approved in United States for the following indications:
- Stress reduction
- Depression management
- Burnout prevention